Anticalcifying nanoparticle antibody titer is an independent risk factor for coronary artery calcification

TULUNAY KAYA C., ERTAŞ F. S., Hasan T., CANDEMİR B., ÖZDÖL Ç., Akan O. A., ...Daha Fazla

CORONARY ARTERY DISEASE, cilt.22, sa.6, ss.394-400, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 6
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1097/mca.0b013e3283487d7f
  • Dergi Adı: CORONARY ARTERY DISEASE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.394-400
  • Anahtar Kelimeler: antibody, calcifying nanoparticles, coronary artery calcification, electron beam computed tomography, multidetector computed tomography, nanobacteria, HEART-DISEASE EVENTS, ELECTRON-BEAM, COMPUTED-TOMOGRAPHY, PROGNOSTIC VALUE, PSAMMOMA BODIES, CALCIUM SCORE, YOUNG-ADULTS, NANOBACTERIA, SERUM, ATHEROSCLEROSIS
  • Ankara Üniversitesi Adresli: Evet

Özet

Background Calcium phosphate deposition is present even in the early phases of the atherosclerotic plaque formation. Calcifying nanoparticles (CNPs), previously known as nanobacteria, have emerged as a potential causative agent for pathological calcification in human vasculature. This study investigates the relationship between the anti-CNPs antibody titers and the extent of coronary calcification.